Protein Degradation

Edited By: Karen Young Kreeger C.L. Ward, S. Omura, R.R. Kopito, "Degradation of CFTR by the ubiquitin-proteasome pathway," Cell, 83:121-7, 1995. (Cited in nearly 50 publications as of March 1997) Comments by Ron R. Kopito and Cristina L. Ward, Department of Biological Sciences, Stanford University 'LIFTING OF THE VEIL': Stanford’s Ron Kopito and Cristina Ward identified a membrane protein involved in the ubiquitin-proteasome pathway. This paper is the first to identify a plasma membra

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Edited By: Karen Young Kreeger
C.L. Ward, S. Omura, R.R. Kopito, "Degradation of CFTR by the ubiquitin-proteasome pathway," Cell, 83:121-7, 1995. (Cited in nearly 50 publications as of March 1997) Comments by Ron R. Kopito and Cristina L. Ward, Department of Biological Sciences, Stanford University


'LIFTING OF THE VEIL': Stanford’s Ron Kopito and Cristina Ward identified a membrane protein involved in the ubiquitin-proteasome pathway.
This paper is the first to identify a plasma membrane protein whose degradation appears to be critically dependent on the ubiquitin-proteasome pathway. This pathway-where specific cellular proteins are broken down-has become a hot area of research in the last two years.

What started off as a "trickle of interest in the field -more or less with our paper-has turned into a geyser of subsequent papers," observes Ron Kopito, a professor of biology at Stanford University. His lab worked with a protein called the cystic fibrosis transmembrane ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies